TRVI — Trevi Therapeutics Inc. price, chart and key statistics

Price data

Price

$12.83

YTD price return

+2.48%

YTD total return

+2.48%

Next earnings

Nov 12, 2026

Market cap

1.8B2019-06 133.8M2026-10 1.8B+1266.6% over the window

Enterprise value

1.5B

Shares outstanding

142.5M2018-12 438.6K2026-06 142.5M+32384.2% over the window

52W low

$9.82

52W high

$20.22

From 52W high

-36.55%

From 52W low

+30.65%

52W range

29%

Volume

Rel volume

0.75×

30D volume

2.4M

30D $ vol

33.5M

Fundamentals

EPS (ttm)

-$0.342021-06 -$1.742026-06 -$0.34-80.2% over the window

FCF (ttm)

-52.9M2018-12 -18.4M2026-06 -52.9M+186.6% over the window

FCF/share

-$0.372018-12 -$42.062026-06 -$0.37-99.1% over the window

Book value/share

$2.262018-12 -$249.642026-06 $2.26-100.9% over the window

ROE

-15.90%2019-12 -47.8%2026-06 -15.9%-66.7% over the window

ROA

-15.46%2018-12 -195.2%2026-06 -15.5%-92.1% over the window

Current ratio

37.282018-12 3.302026-06 37.28+1030.7% over the window

Growth (CAGR, ttm) · 10Y

Shares

+17.01%2025-06-30 → 2026-06-30121.8M → 142.5M (+17.0% total)+30.67%2023-06-30 → 2026-06-3063.9M → 142.5M (+123.1% total)+45.84%2021-06-30 → 2026-06-3021.6M → 142.5M (+559.7% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+38.47%2025-06-30 → 2026-06-30$1.63 → $2.26 (+38.4% total)+14.86%2023-06-30 → 2026-06-30$1.49 → $2.26 (+51.6% total)+22.41%2021-06-30 → 2026-06-30$0.82 → $2.26 (+174.8% total)n/a

Price

+20.03%2025-10-20 → 2026-10-20$10.69 → $12.83 (+20.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+92.78%2023-10-20 → 2026-10-20$1.79 → $12.83 (+616.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+58.82%2021-10-20 → 2026-10-20$1.27 → $12.83 (+910.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+20.03%2025-10-20 → 2026-10-20$10.69 → $12.83 (+20.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+92.78%2023-10-20 → 2026-10-20$1.79 → $12.83 (+616.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+58.82%2021-10-20 → 2026-10-20$1.27 → $12.83 (+910.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-37.2×2019-06 -6.512026-10 -35.77+449.4% over the window

Fwd P/E

-22.2×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

5.7×2019-06 -1.162026-10 5.69-590.8% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-2.89%2019-12 -34.5%2026-06 -2.0%-94.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 142.5M ÷ 121.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-17.01%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-17.01%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($666.1M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-17.01%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.

0.00%2019-12 0.0%2026-06 0.0%

Vs own 10Y history

P/B

78th